Tag: ER-positive breast cancer patients
Drug candidate offers hope for ER-positive breast cancer patients
An international research collaboration, spearheaded by Pfizer in partnership with Monash University and the Cancer Therapeutics Cooperative Research Centre in Australia, has identified a promising pre-clinical drug candidate with potential anti-tumour activity against Estrogen Receptor (ER) positive breast cancer.
Featured Article
Don’t get left behind: Manufacturing’s urgent need for digital transformation
As digital transformation reshapes industries worldwide, manufacturers in Australia and beyond are finding themselves at the forefront of an evolution. This shift presents opportunities for companies looking to improve efficiency, drive innovation, and boost growth.
